Peter Düwell

9PUBLICATIONS
81CO-AUTHORS
Innate immunityCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsTumour immunologyAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 25, 2026
RIG-I-targeted immunotherapy synergizes with immune checkpoint inhibition in a hepatocellular carcinoma model.

|Jan 22, 2026
RIG-I agonists promote antigen-spreading and facilitate durable CAR-T responses in pancreatic ductal adenocarcinoma.

Anne Marie Senz, Bruno L Cadilha, Julia Teppert

|Feb 09, 2023
IL18 Receptor Signaling Regulates Tumor-Reactive CD8+ T-cell Exhaustion via Activation of the IL2/STAT5/mTOR Pathway in a Pancreatic Cancer Model.

Veronika Lutz, Veronique M Hellmund, Felix S R Picard

|Sep 23, 2021
BTK operates a phospho-tyrosine switch to regulate NLRP3 inflammasome activity.

Zsófia Agnes Bittner, Xiao Liu, Maria Mateo Tortola

|Jul 17, 2021
OAS1/RNase L executes RIG-I ligand-dependent tumor cell apoptosis.

Daniel F R Boehmer, Simone Formisano, Carina C de Oliveira Mann

|May 26, 2020
Systemic but not MDSC-specific IRF4 deficiency promotes an immunosuppressed tumor microenvironment in a murine pancreatic cancer model.

Philipp Metzger, Sabrina V Kirchleitner, Daniel F R Boehmer

Pageof 2

Frequent Collaborators

5 joint publications

Lars M König

4 joint publications

Philipp Metzger

4 joint publications

Stefan Endres

3 joint publications

Simon Rothenfusser